Pfizer launches study of omicron-specific COVID-19 vaccine

Norge Nyheter Nyheter

Pfizer launches study of omicron-specific COVID-19 vaccine
Norge Siste Nytt,Norge Overskrifter
  • 📰 verge
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 67%

Boosters still protect against severe disease.

Omicron has a slate of mutations that makes it more difficult for antibodies produced against the original form of the virus, which are the types generated by the vaccines, to block it. The hope is that an omicron-specific form of the vaccine, which should push the body to produce omicron-specific antibodies, would provide longer-lasting protection against infection, mild illness, and serious cases of COVID-19.

The newly launched study will test an omicron-specific shot in 1,420 people. People who have already received two doses of the original vaccine will get an additional one or two doses of the omicron-specific shot. People who have already received three doses of the original will get either an additional dose of the original or one dose of the omicron shot. And a third set of people who have never been vaccinated will get three doses of the omicron-specific shot.

“This study is part of our science-based approach to develop a variant-based vaccine that achieves a similar level of protection against omicron as it did with earlier variants but with longer duration of protection,” said Ugur Sahin, CEO and co-founder of BioNTech, in a

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

verge /  🏆 94. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyPfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Les mer »

Covid-19 news: Strain on health services led to extra non-covid deathsCovid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults
Les mer »

Pfizer says it's starting clinical studies of an omicron-based COVID-19 vaccinePfizer says it's starting clinical studies of an omicron-based COVID-19 vaccinePfizer and BioNTech said Tuesday they've stated clinical trials for an omicron-based COVID-19 vaccine.
Les mer »

COVID-19 patient from Minnesota at center of ventilator controversy dies in Texas, media reports sayCOVID-19 patient from Minnesota at center of ventilator controversy dies in Texas, media reports sayMINNEAPOLIS — A unvaccinated COVID-19 patient flown from Minnesota to Houston during a legal battle over whether his ventilator should be turned off died...
Les mer »

New Zealand Prime Minister Jacinda Ardern cancels wedding amid new COVID-19 restrictionsNew Zealand Prime Minister Jacinda Ardern cancels wedding amid new COVID-19 restrictions'Such is life,' she said when asked about the cancellation.
Les mer »

COVID-19 Testing Site Set To Open In Beverly Hills Sunday EveningCOVID-19 Testing Site Set To Open In Beverly Hills Sunday EveningAn additional testing center capable of administering up to 2,000 tests a day is set to open in Beverly Hills on Sunday night.
Les mer »



Render Time: 2025-04-10 14:03:11